Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-course dipyridamole for protection against forearm ischemia-reperfusion injury
NL-OMON31190Phase 4Not yet recruiting
- Sponsor
- Radboud University Medical Center
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dipyridamole in ischemia-reperfusion injury (IRI) (2 arms), sponsored by Radboud University Medical Center. Planned start May 2007; status: not yet recruiting.
02
Drugs
dipyridamole
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NL-OMON31190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31190.